[HTML][HTML] Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease
Neurofibrillary tangles, composed of insoluble aggregates of the microtubule-associated
protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. …
protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. …
[HTML][HTML] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …
Reassessing B cell contributions in multiple sclerosis
There is growing recognition that B cell contributions to normal immune responses extend
well beyond their potential to become antibody-producing cells, including roles at the innate–…
well beyond their potential to become antibody-producing cells, including roles at the innate–…
Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport
Aggregation and accumulation of the microtubule-associated protein tau are associated with
cognitive decline and neuronal degeneration in Alzheimer’s disease and other tauopathies. …
cognitive decline and neuronal degeneration in Alzheimer’s disease and other tauopathies. …
Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases
…, NE LaPointe, GF Pigino, KR Patterson… - Journal of …, 2011 - Soc Neuroscience
Aggregated filamentous forms of hyperphosphorylated tau (a microtubule-associated protein)
represent pathological hallmarks of Alzheimer's disease (AD) and other tauopathies. While …
represent pathological hallmarks of Alzheimer's disease (AD) and other tauopathies. While …
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease
PM Horowitz, KR Patterson… - Journal of …, 2004 - Soc Neuroscience
Alzheimer's disease (AD) is a progressive amnestic dementia that involves post-translational
hyperphosphorylation, enzymatic cleavage, and conformational alterations of the …
hyperphosphorylation, enzymatic cleavage, and conformational alterations of the …
Mechanisms of C aspr2 antibodies in autoimmune encephalitis and neuromyotonia
KR Patterson, J Dalmau, E Lancaster - Annals of neurology, 2018 - Wiley Online Library
Objective To determine the pathogenic mechanisms of autoantibodies to the cell adhesion
molecule Caspr2 in acquired neuromyotonia and autoimmune encephalitis. Methods Caspr2‐…
molecule Caspr2 in acquired neuromyotonia and autoimmune encephalitis. Methods Caspr2‐…
Tau as a therapeutic target in neurodegenerative disease
…, SM Ward, JK Lancia, KR Patterson… - Pharmacology & …, 2012 - Elsevier
Tau is a microtubule-associated protein thought to help modulate the stability of neuronal
microtubules. In tauopathies, including Alzheimer's disease and several frontotemporal …
microtubules. In tauopathies, including Alzheimer's disease and several frontotemporal …
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
…, A Rezk, I Mexhitaj, KR Patterson… - Proceedings of the …, 2023 - National Acad Sciences
A small proportion of multiple sclerosis (MS) patients develop new disease activity soon
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …
Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies
E Burnor, L Yang, H Zhou, KR Patterson, C Quinn… - Neurology, 2018 - AAN Enterprises
Objective To measure the frequency, persistence, isoform specificity, and clinical correlates
of neurofascin antibodies in patients with peripheral neuropathies. Methods We studied …
of neurofascin antibodies in patients with peripheral neuropathies. Methods We studied …
